When HCC patients were compared with CLD and LC patients, the AUC for thioredoxin was also larger than that for AFP (0.901, 0.875–0.923 vs. 0.842, 0.821–0.889, P = 0.002; Table 3). This evidence concerns the gene AFP and laryngotracheoesophageal cleft.